2017-2020 NHANES HF Prevalence by Age Categories
Prevalence, prevalence by age, age categories, prevalence in the US, US prevalence, NHANES, CDC statistics, US, United States
Prevalence, prevalence by age, age categories, prevalence in the US, US prevalence, NHANES, CDC statistics, US, United States
Prevalence, future projection, future forecast, future trends, current trends, trends in the US, impact in the US, US prevalence, prevalence in the US, forecasting, burden of cardiovascular disease, increase in HF cases, number of people with HF, US, United States
incidence rates, incidence in US, US incidence, Mesa study, MESA, cohort studies, stratified by race/ethnicity, race, ethnicity, blacks, hispanics, whites, chinese, racial differences, US, United States
Incidence, Etiology, distribution across age groups, age groups, sex differences, stratified by sex, males and females, males, females, ischemic heart disease, hypertensive heart disease, cardiomyopathy, mitral valve disease, rheumatic heart disease, valve disease, endocarditis, myocarditis, Chagas disease, immune disorders, G6PD deficiency, thalassemia, cogenital heart disease, worldwide, global, 2019
Incidence, Lifetime risk, Framingham study, FHS, cohort studies, number of people at risk, US, United States
Key Points Approximately 6.7 million Americans over 20 years of [...]